SCHEMBL3196140

SCHEMBL3196140

C=Cc1ccc(CCCCC(=O)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.59
RXFP1 Q9HBX9 1/20 0.59
SMN1; SMN2 Q16637 2/20 0.53
HDAC3 O15379 1/20 0.53
MAPK1 P28482 1/20 0.53
ADRA1A P35348 1/20 0.53
HDAC4 P56524 1/20 0.53
SLC6A3 Q01959 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC2 Q92769 1/20 0.53
HDAC10 Q969S8 1/20 0.53
HDAC11 Q96DB2 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
HDAC9 Q9UKV0 1/20 0.53
HDAC5 Q9UQL6 1/20 0.53
HSD17B10 Q99714 1/20 0.50
FFAR1 O14842 3/20 0.47
TBXAS1 P24557 7/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3626622 0.98 MAPT (0.58) MAPTRXFP1SMN1; SMN2HDAC3MAPK1
SCHEMBL5180251 0.98 MAPT (0.62) MAPTRXFP1SMN1; SMN2HDAC3MAPK1
SCHEMBL5180930 0.98 MAPT (0.62) MAPTRXFP1SMN1; SMN2HDAC3MAPK1
SCHEMBL5078015 0.98 MAPT (0.62) MAPTRXFP1SMN1; SMN2HDAC3MAPK1
SCHEMBL3628000 0.98 MAPT (0.62) MAPTRXFP1SMN1; SMN2HDAC3MAPK1
SCHEMBL5176085 0.98 MAPT (0.62) MAPTRXFP1SMN1; SMN2HDAC3MAPK1
Hydrochloric Acid SCHEMBL3620483 0.97 MAPT (0.61) MAPTRXFP1SMN1; SMN2HDAC3MAPK1
SCHEMBL3618282 0.95 SMN1; SMN2 (0.60) MAPTRXFP1SMN1; SMN2HDAC3MAPK1
Hydrochloric Acid SCHEMBL3618619 0.93 SMN1; SMN2 (0.58) MAPTRXFP1SMN1; SMN2HDAC3MAPK1
SCHEMBL9680690 0.87 THRB (0.44) MAPTRXFP1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1236752-B1 Polyhydroxyalkanoate polyester having vinyl phenyl structure in the side chain and its production method CANON KK (JP) 2007-01-03 EP claimed
US-6803444-B2 POLYHYDROXYALKANOATE POLYESTER FOR USE IN THE GENERATION OF BIODEGRADABLE PRODUCTS CANON KABUSHIKI KAISHA (JP) 2004-10-12 US claimed
US-20030059907-A1 Polyhydroxyalkanoate polyester having vinyl phenyl structure in the side chain and its production method CANON KABUSHIKI KAISHA (JP) 2003-03-27 US claimed
EP-1236752-A2 Polyhydroxyalkanoate polyester having vinyl phenyl structure in the side chain and its production method CANON KABUSHIKI KAISHA (JP) 2002-09-04 EP claimed
US-20210388259-A1 LIGAND, LIGAND QUANTUM DOT, QUANTUM DOT LAYER AND METHOD FOR PATTERNING THE SAME BOE TECHNOLOGY GROUP CO., LTD. (CN) 2021-12-16 US disclosed
WO-2021063166-A1 LIGAND, COORDINATED QUANTUM DOT, QUANTUM DOT LAYER AND PATTERNING METHOD THEREFOR 京东方科技集团股份有限公司 2021-04-08 WO disclosed
CN-111378164-A Force-responsive polymer with multi-covalent cross-linked network 翁秋梅 2020-07-07 CN disclosed
CN-1537876-B Multi-branch polymer, its production method and its application MITSU CHEMICALS INC 2013-01-16 CN disclosed
US-7795347-B2 Multi-branched polymer, process for producing the same, and applications thereof MITSUI CHEMICALS, INC. (JP) 2010-09-14 US disclosed
US-7682765-B2 Toner for developing electrostatic images CANON KABUSHIKI KAISHA (JP) 2010-03-23 US disclosed
US-7638590-B2 Polyhydroxyalkanoate having amide, sulfonic acid or sulfonate ester group, charge control agent and toner CANON KABUSHIKI KAISHA (JP) 2009-12-29 US disclosed
EP-1396504-B1 Polyolefin macromonomer, graft polymer obtained from the polyolefin macromonomer, and use thereof MITSUI CHEMICALS INC (JP) 2009-01-14 EP disclosed
CN-1445257-A Polyhydroxy alkanoate copolymer and its preparation method CANON KK (JP) 2003-10-01 CN disclosed
CN-1440992-A Molecular weight control method of poly hydroxy alkane acid ester CANON KK (JP) 2003-09-10 CN disclosed
CN-1440991-A Polyhydroxy alkane acid ester, its preparing process, charge controling agent containing its, toner adhesive and toner and image forming method using said toner and forming device of image CANON KK (JP) 2003-09-10 CN disclosed
EP-1340777-A1 Novel polyhydroxyalkanoate, method of producing the same, charge controlling agent containing polyhydroxyalkanoate, toner binder and toner, and image formation method and image forming apparatus using toner CANON KABUSHIKI KAISHA (JP) 2003-09-03 EP disclosed
EP-1340778-A1 Polyhydroxyalkanoates containing a vinylphenyl structure in their side chain and method of manufacturing the same CANON KABUSHIKI KAISHA (JP) 2003-09-03 EP disclosed
EP-1340776-A1 Method for controlling molecular weight of polyhydroxyalkanoate constituted of units containing residue of phenyl-, thienyl-, or cyclohexyl-structure in side chain of molecule CANON KABUSHIKI KAISHA (JP) 2003-09-03 EP disclosed
US-20030059907-A1 Polyhydroxyalkanoate polyester having vinyl phenyl structure in the side chain and its production method CANON KABUSHIKI KAISHA (JP) 2003-03-27 US disclosed
EP-1236752-A2 Polyhydroxyalkanoate polyester having vinyl phenyl structure in the side chain and its production method CANON KABUSHIKI KAISHA (JP) 2002-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210388259-A1 LIGAND, LIGAND QUANTUM DOT, QUANTUM DOT LAYER AND METHOD FOR PATTERNING THE SAME CD2, EPCAM, L1CAM MAPT 1774/4885RXFP1 3978/4885SMN1; SMN2 4517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.